Geographic variation and racial disparities in adoption of newer glucose-lowering drugs with cardiovascular benefits among US Medicare beneficiaries with type 2 diabetes.

Geographic variation and racial disparities in adoption of newer glucose-lowering drugs with cardiovascular benefits among US Medicare beneficiaries with type 2 diabetes.

<h4>Background</h4>Prior studies have shown disparities in the uptake of cardioprotective newer glucose-lowering drugs (GLDs), including sodium-glucose cotranwsporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP1a). This study aimed to characterize geographic...

Full description

Bibliographic Details
Main Authors: Wei-Han Chen, Yujia Li, Lanting Yang, John M Allen, Hui Shao, William T Donahoo, Lori Billelo, Xia Hu, Elizabeth A Shenkman, Jiang Bian, Steven M Smith, Jingchuan Guo
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0297208

Internet

https://doi.org/10.1371/journal.pone.0297208

Similar Items